BFC Planning, Inc.’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.8K Buy
312
+11
+4% +$1.2K ﹤0.01% 1585
2026
Q1
$27.8K Hold
301
– – ﹤0.01% 1568
2025
Q4
$30.7K Buy
301
+9
+3% +$805 ﹤0.01% 1561
2025
Q3
$18.2K Sell
292
-13
-4% -$707 ﹤0.01% 1619
2025
Q2
$15.9K Hold
305
– – ﹤0.01% 1601
2025
Q1
$13K Buy
305
+13
+4% +$561 ﹤0.01% 1653
2024
Q4
$8.92K Buy
+292
New +$8.21K ﹤0.01% 1812

Other funds holding GH

BFC Planning, Inc.'s GH Position: Q2 2026 in Review

BFC Planning, Inc. increased its Guardant Health (GH) stake by 3.7% in Q2 2026, buying an estimated $1.2K and bringing the position to 312 shares worth $46.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1585.

BFC Planning, Inc. first reported a position in GH in Q4 2024 and has held it in 7 quarters since. 604 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • BFC Planning, Inc. held 312 shares of Guardant Health worth $46.8K as of Q2 2026.
  • BFC Planning, Inc. bought 11 Guardant Health shares in Q2 2026, an estimated $1.2K.
  • Guardant Health made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #1585 holding.
  • BFC Planning, Inc. first reported a position in Guardant Health in Q4 2024 and has held it in 7 quarters since.
  • 604 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.